Rossari, F., Lavacchi, D., Alimenti, E., Soldà, C., Salani, F., Esposito, L., . . . Casadei-Gardini, A. Early bevacizumab dose and time modifications may affect efficacy of atezolizumab plus bevacizumab for advanced hepatocellular carcinoma treatment. Elsevier.
Chicago Style (17th ed.) CitationRossari, F., et al. Early Bevacizumab Dose and Time Modifications May Affect Efficacy of Atezolizumab Plus Bevacizumab for Advanced Hepatocellular Carcinoma Treatment. Elsevier.
MLA (9th ed.) CitationRossari, F., et al. Early Bevacizumab Dose and Time Modifications May Affect Efficacy of Atezolizumab Plus Bevacizumab for Advanced Hepatocellular Carcinoma Treatment. Elsevier.
Warning: These citations may not always be 100% accurate.